About Cell Line Development Cell line development is the process by which prokaryotic (bacteria, virus, protozoa) and eukaryotic (animals, plants) cells are allowed to grow under precise conditions. But in practice, cell line development is generally derived from animal cells which includes mammals, insects and amphibians. The cells are removed from tissue and separated through enzymatic or mechanical process which is further used for cultivation. Technavio’s analysts forecast the global cell line development market to grow at a CAGR of 12.27% during the period 2017-2021. Covered in this report The report covers the present scenario and the growth prospects of the global cell line development market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sale of cell line development system. The market is divided into the following segments based on geography: • Americas • APAC • EMEA Technavio's report, Global Cell Line Development Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over... Research Beam Model: Research Beam Product ID: 1697019 3500 USD New
Global Cell Line Development Market 2017-2021
 
 

Global Cell Line Development Market 2017-2021

  • Category : Semiconductor and Electronics
  • Published On : July   2017
  • Pages : 81
  • Publisher : Technavio
 
 
 
About Cell Line Development

Cell line development is the process by which prokaryotic (bacteria, virus, protozoa) and eukaryotic (animals, plants) cells are allowed to grow under precise conditions. But in practice, cell line development is generally derived from animal cells which includes mammals, insects and amphibians. The cells are removed from tissue and separated through enzymatic or mechanical process which is further used for cultivation.

Technavio’s analysts forecast the global cell line development market to grow at a CAGR of 12.27% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global cell line development market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sale of cell line development system.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio's report, Global Cell Line Development Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• GE Healthcare
• Lonza
• Merck Millipore
• Thermo Fisher Scientific

Other prominent vendors
• Cobra Biologics
• Corning
• Molecular Devices
• sartorious
• SELEXIS
• WuXi Biologics

Market driver
• Increased demand for monoclonal antibodies
• For a full, detailed list, view our report

Market challenge
• Development of authentic cell lines
• For a full, detailed list, view our report

Market trend
• Increase demand for regenerative medicine
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.




PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
• Market outline
PART 05: Market landscape
• Market size and forecast
• Five forces analysis
PART 06: Market segmentation by product
• Global cell line development market by product type
• Global cell line development market by media and reagents
• Global cell line development market by equipment
PART 07: Geographical segmentation
• Global cell line development market by geography
• Cell line development market in Americas
• Cell line development market in EMEA
• Cell line development market in APAC
PART 08: Decision framework
PART 09: Drivers and challenges
• Market drivers
• Market challenges
PART 10: Market trends
• Increase demand for regenerative medicine
• Adoption of laboratory automation
• Growing prevalence of autoimmune diseases and cancer
PART 11: Vendor landscape
• Competitive scenario
• Investment opportunity
PART 12: Key vendor analysis
• GE Healthcare
• Lonza
• Merck Millipore
• Thermo Fisher Scientific
• Other prominent vendors
PART 13: Appendix
• List of abbreviations

PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter

 
 
REQUEST SAMPLE    ASK FOR DISCOUNT